As the rapid expansion of biologics continues, today’s high‑concentration injectables, prefilled syringes and cartridges, as ...

Overcoming common challenges with today’s biologics, such as developing devices for high-concentration subcutaneous ...

From quality-led differentiation to digital alignment and regional strategy, CDMOs are redefining how they compete in a more ...

From legacy therapeutics to next-generation GLP-1s, advances in synthesis, analysis, and regulation are reshaping how peptide ...